Ionis Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of…

Biotechnology
US, Carlsbad [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of IONS's Analysis
CIK: 874015 CUSIP: 462222100 ISIN: US4622221004 LEI: - UEI: -
Secondary Listings
IONS has no secondary listings inside our databases.